TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
ANAB

AnaptysBio Inc

Healthcare · Biotechnology

50.80$ -5.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

AnaptysBio Inc (ANAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 20 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ANAB
Line item 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-5.8 15 -9.7 -9.0 -19 -49 -70 -14 -46 -74 -121 -135 20
0.6 0.3 0.3 0.2 0.2 0.3 0.5 0.6 2.1 2.3 2.4 2.4 2.4
0.2 0.2 0.6 1.2 4.4 10.0 12 11 15 27 33 34 36
1.5 2.0 2.0 6.4 -0.6 0.7 12 1.9 19
-1.2 9.3 -6.5 -7.0 4.1 3.5 17 -6.8 -7.5 6.8 -0.3 -66 -81
0.0 0.1 0.2 0.1 0.3 1.1 0.8 0.6 1.4 0.4 0.8 0.4 0.1
0.0 -0.1 -0.2 -0.1 -243 -142 131 94 39 -395 145 95 228
0.0 12
0.2 41 0.0 294 230 3.0 0.5 2.6 12 -50 -0.5 -69
5.0 10 10 -6.9 -6.9 -7.5 -1.4 0.0 0.0
2.0 4.9 39 8.6 292 223 -4.5 -0.9 252 44 -59 127 -133
-3.9 19 29 -0.5 30 32 57 79 245 -424 -35 87 115
-5.8 14 -9.9 -9.1 -20 -50 -70 -15 -47 -74 -122 -136 20

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?